It has not been possible to determine which symptoms are due to carnitine deficiency and which are due to an underlying organic acidemia, as symptoms of both abnormalities may be expected to improve with Levocarnitine Oral Solution USP
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinsons disease: a randomised, double-blind, placebo-controlled trial
Because vitamin B12 amplifies the effectiveness of NAD+, particularly in patients with fatigue, mood instability, or low blood levels of B12
Established risk factors include female sex, age over 40 years, obesity, rapid weight loss, family history of gallstones, certain ethnic backgrounds (particularly Native American and Hispanic populations), pregnancy, and metabolic conditions such as diabetes and dyslipidemia